News

NurExone Biologic to Showcase ExoPTEN Therapy Innovations

NurExone Biologic to Showcase ExoPTEN Therapy Innovations

NurExone Biologic Invited to Present at Key Conferences

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) is thrilled to share that its Chief Executive Officer, Dr. Lior Shaltiel, has received invitations to present at several prestigious upcoming conferences. This recognition highlights the Company's dedication to advancing exosome research for clinical applications and regenerative medicine.

ExoPTEN Therapy Presentation

During his presentation, Dr. Shaltiel will showcase NurExone's groundbreaking ExoPTEN nanodrug, which holds promise as a potential treatment for acute spinal cord injuries and various central nervous system disorders, including glaucoma. His talk will focus on "A Comparative Analysis of AbbVie and NurExone's Approaches to Effective Spinal Cord Injury Treatment." This conference is a key event in the bioprocessing and manufacturing sector, providing opportunities to engage with industry leaders, researchers, and potential collaborators.

Participation Details

In addition to the Bioprocess International Conference, Dr. Shaltiel is also set to be a panelist at the Pioneering Israel Medicine Conference. He will share valuable insights about NurExone's pioneering work in exosomes for regenerative medicine. Notably, this event will also feature the esteemed Nobel Prize Laureate Professor Aaron Ciechanover, adding to the event's significance.

Significance of Exosome Technologies

Dr. Shaltiel's participation in these influential conferences underscores NurExone's growing presence and impact in the regenerative medicine field. The research and innovations presented are expected to resonate with many stakeholders eager to learn about advancements in exosome technologies.

About NurExone Biologic Inc.

NurExone Biologic Inc. is a pharmaceutical company listed on the TSX Venture Exchange (TSXV) and OTCQB, dedicated to developing biologically-guided exosome-based therapies aimed at helping patients with central nervous system injuries. The Company's flagship product, ExoPTEN, has demonstrated remarkable efficacy, recovering motor functions in 75% of laboratory rats when administered intranasally. Additionally, the product has received Orphan Drug Designation from the FDA, highlighting its potential therapeutic benefits.

Innovative Drug Delivery Solutions

NurExone's platform technology is expected to introduce innovative solutions for pharmaceutical companies interested in non-invasive drug delivery systems. With a strong emphasis on safety and efficacy, the advancements in exosome technology open new pathways for treating a variety of medical conditions.

Contact Information

For further information or inquiries, please contact:

Dr. Lior Shaltiel
Chief Executive Officer and Director
Phone: +972-52-4803034
Email: info@nurexone.com

Thesis Capital Inc.
Investor Relations - Canada
Phone: +1 905-347-5569
Email: IR@nurexone.com

Dr. Eva Reuter
Investor Relations - Germany
Phone: +49-69-1532-5857
Email: e.reuter@dr-reuter.eu

Allele Capital Partners
Investor Relations - US
Phone: +1 978-857-5075
Email: aeriksen@allelecapital.com

Frequently Asked Questions

What is NurExone Biologic known for?

NurExone Biologic specializes in developing exosome-based therapies, particularly focusing on treating central nervous system injuries.

Who is Dr. Lior Shaltiel?

Dr. Lior Shaltiel is the Chief Executive Officer of NurExone Biologic Inc., leading the company's innovative research initiatives.

What are ExoPTEN's applications?

ExoPTEN is being explored as a treatment for acute spinal cord injuries and other central nervous system conditions.

What prestigious events will NurExone participate in?

NurExone will participate in the Bioprocess International Conference and the Pioneering Israel Medicine Conference.

How effective is ExoPTEN based on studies?

ExoPTEN has shown a significant recovery of motor function in 75% of laboratory rats when administered intranasally.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 1

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
China Hour Expands Chinese Media Footprint in Africa

Updated Category News Views 3

An Ambitious Cross-Continental Media Play The airwaves are getting a new twist. This time, it's a blend of cultures, as China Hour makes an entrance in South Africa. That's right, folks—Jiangsu Broadcasting Corporation (JSBC) has set up camp alongside the South African Broadcasting Corporation (SABC), pushing a big media wave across the continent. If you've been...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 2

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
LiberNovo Demos Ergonomic Seating at IFA 2026

Updated Category News Views 2

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 0

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 3

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 10

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 1

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 2

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading

Top 5 Most Recently Viewed Articles

Wellcome Grants $6.5M to System for Global Knowledge Integration

Updated Category News Views 138

Wellcome Invests in System's Vision for Interconnected Knowledge System, a Public Benefit Corporation, has recently been awarded a significant $6.5 million program-related investment from the Wellcome Trust. This funding marks an important milestone, being one of the first investments in public interest technology by Wellcome, aimed to bolster the development of the...

Continue Reading
Premier Health Secures Contract for Independent Labour Supply

Updated Category News Views 59

Premier Health's New Service Contract Announcement Premier Health of America Inc. (TSXV: PHA) has secured a significant contract to provide independent labor services to the healthcare sector. This announcement signals a major step in improving healthcare delivery in the Outaouais region of Quebec. With its commitment to enhancing patient care, Premier Health is...

Continue Reading
Celebrating the Innovators of Financial Marketing & Communications

Updated Category News Views 171

Introducing the Financial Narrative 50 (FN50) In the vibrant world of financial marketing and communications, a select group of professionals stands out each year. Financial Narrative, a premier organization dedicated to this field, has unveiled its annual FN50 list. This exclusive honor is awarded to individuals who are not just leaders but visionaries, influencing the...

Continue Reading
Longeveron Inc. Embraces Leadership Changes for Growth

Updated Category News Views 148

Longeveron Inc. Announces Leadership Transformations Longeveron Inc. is a clinical-stage biotechnology company focused on developing regenerative therapies. Recently, the company announced some pivotal leadership changes that are set to position it for future success. Interim CEO Appointment Than Powell, previously the Chief Business Officer and a key player in business...

Continue Reading
Strategic Partnership Between Glass House Brands and LEEF

Updated Category News Views 200

Strategic Collaboration Between Glass House Brands and LEEF In a significant move in the cannabis industry, LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) has entered into a groundbreaking Management Services Agreement (MSA) with Glass House Brands, Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF). This agreement aims to combine Glass House's...

Continue Reading